'Latent' carcinoma of the prostate: A medical misnomer?

Urology

Volumn 56, Issue 4, 2000, Pages 708-711

  Selman, Steven H ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SIZE; HUMAN; MALE; NOMENCLATURE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROSTATE CARCINOMA; SEMINAL VESICLE; TUMOR LOCALIZATION;

EID: 0033825311     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00618-X     Document Type: Review

References (29)

1. Rich A.R. On the frequency of occurrence of occult carcinoma of the prostate. J Urol. 33:1935;215-223.
2. Andrews G.S. Latent carcinoma of the prostate. J Clin Pathol. 2:1949;197-208.
3. Franks L.M. Latent carcinoma of the prostate. Pathol Bact. 68:1954;603-616.
4. Greene L.F., Simon H.B. Occult carcinoma of the prostate clinical and therapeutic study of eighty-three cases . JAMA. 158:1955;1494-1498.
5. Edwards C.N., Steinthorsson M.D., Nicholson D. An autopsy study of latent prostatic cancer. Cancer. 6:1953;531-554.
6. Guileyardo J.M., Sarma D.P., Johnson W.D., et al. Incidental prostatic carcinoma tumor extent versus histologic grade . Urology. 20:1982;40-42.
7. Scardino P.T. Early detection of prostate cancer. Urol Clin North Am. 16:1989;635-655.
8. Stamey T.A., Freiha F.S., McNeal J.E., et al. Localized prostate cancer. Cancer. 71:1993;933-938.
9. Karube K. Study of latent carcinoma of the prostate in the Japanese based on necropsy material. Tohoku J Exp Med. 74:1961;265-285.
10. Akazaki K., Stemmerman G.N. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst. 50:1973;1137-1144.
11. Lee Y.S., Shanmugaratnam K. Latent prostate carcinoma in Singapore Chinese. Singapore Med J. 13:1972;1-6.
12. Breslow N., Chan C.W., Dhom G., et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer. 20:1977;680-688.
13. Furusato M., Wakui S., Sasaki H., et al. Tumor angiogenesis in latent prostatic carcinoma. Br J Cancer. 70:1994;1244-1246.
14. Moore R.A. The morphology of small prostatic carcinoma. J Urol. 33:1935;224-234.
15. Ratanchandi G.T., Chaphekar P.M. Study of latent carcinoma of the prostate by step section technique. Indian J Cancer. 9:1972;112-120.
16. Lundberg S., Berge T. Prostatic carcinoma, an autopsy study. Scand J Urol Nephrol. 4:1970;93-97.
17. Brawn P.N., Kuhl D., Spreights V.O., et al. The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma. Arch Pathol Lab Med. 119:1995;731-733.
18. Franks L.M. An historical perspective of the pathology and treatment. Preventing prostate cancer screening versus chemoprevention . Cancer Surv. 23:1995;303-307.
19. Bosland M.C. The etiopathogenesis of prostatic cancer with special reference to environmental factors. Adv Cancer Res. 51:1988;1-106.
20. Ashley D.J.B. On the incidence of carcinoma of the prostate. J Pathol Bact. 90:1965;217-224.
21. McNeal J.E., Kindrachuck R.A., Freiha F.S., et al. Patterns of progression in prostate cancer. Lancet. 1:1986;60-63.
22. Carter H.B., Piantadosi S., Isaacs J.T. Clinical evidence for and implications of the multistep development of prostate cancer. J Urol. 143:1990;742-746.
23. Franks L.M., O'Shea J.D., Thompson A.E.R. Mucin in the prostate a histochemical study in normal glands, latent, clinical and colloid cancers . Cancer. 17:1964;983-991.
24. Furusato M., Kato H., Takahashi M., et al. Crystalloids in latent prostatic carcinoma. Prostate. 15:1989;259-262.
25. Konishi N., Nakaoka S., Tsuzuki T., et al. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nucleolar organizer regions (AgNOR). Pathol Int. 44:1994;297-302.
26. Konishi N., Enomoto T., Buzard G., et al. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer. 69:1992;2293-2299.
27. Konishi N., Hiasa Y., Hayashi I., et al. p53 mutations occur in clinical, but not latent, human prostate carcinoma. Jpn J Cancer Res. 86:1995;57-63.
28. Takahashi H., Furusato M., Allsbrook W.C. Jr, et al. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Res. 55:1995;1621-1624.
29. Burton E.C., Troxclair D.A., Newman W.P. III. Autopsy diagnosis of malignant neoplasm how often are clinical diagnoses incorrect? JAMA. 280:1998;1245-1248.